Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics
- PMID: 4087171
- DOI: 10.1007/BF01061479
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics
Abstract
The disposition decomposition approach is employed to derive clearance parameters descriptive of drug distribution kinetics. The name distribution clearance, CLd, is given to a characteristic constant of linear and some nonlinear pharmacokinetic systems. CLd is the clearance associated with the steady-state rate of drug transfer from the peripheral tissues to the systemic circulation. Also introduced is the elimination clearance, CLe, which is associated with the total drug transfer rate from the systemic circulation in linear systems. Estimates of CLd and CLe are presented for several drugs.
Similar articles
-
Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.J Pharmacokinet Biopharm. 1984 Dec;12(6):627-48. doi: 10.1007/BF01059557. J Pharmacokinet Biopharm. 1984. PMID: 6533297
-
Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug.J Pharm Sci. 1986 Dec;75(12):1119-26. doi: 10.1002/jps.2600751202. J Pharm Sci. 1986. PMID: 3559920
-
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.J Pharmacokinet Biopharm. 1987 Jun;15(3):305-25. doi: 10.1007/BF01066324. J Pharmacokinet Biopharm. 1987. PMID: 3668806
-
Drug dosage in renal disease.Clin Pharmacokinet. 1976;1(2):126-34. doi: 10.2165/00003088-197601020-00004. Clin Pharmacokinet. 1976. PMID: 797495 Review.
-
Drug metabolite kinetics.Pharmacol Ther. 1981;15(3):521-52. doi: 10.1016/0163-7258(81)90056-5. Pharmacol Ther. 1981. PMID: 7048351 Review. No abstract available.
Cited by
-
A physiological and system analysis hybrid pharmacokinetic model to characterize carbon tetrachloride blood concentrations following administration in different oral vehicles.J Pharmacokinet Biopharm. 1993 Oct;21(5):551-74. doi: 10.1007/BF01059114. J Pharmacokinet Biopharm. 1993. PMID: 8145131
-
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.J Pharmacokinet Biopharm. 1987 Jun;15(3):281-304. doi: 10.1007/BF01066323. J Pharmacokinet Biopharm. 1987. PMID: 3668805
-
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.Drug Metab Dispos. 2023 Apr;51(4):532-542. doi: 10.1124/dmd.122.001060. Epub 2023 Jan 9. Drug Metab Dispos. 2023. PMID: 36623886 Free PMC article. Review.
-
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).Clin Pharmacokinet. 1989 Dec;17(6):424-40. doi: 10.2165/00003088-198917060-00005. Clin Pharmacokinet. 1989. PMID: 2689041 Review.
-
A technique for calculating the mean time for equilibration of drug distribution using minimal structural assumptions.J Pharmacokinet Biopharm. 1994 Apr;22(2):157-64. doi: 10.1007/BF02353541. J Pharmacokinet Biopharm. 1994. PMID: 7815311
References
MeSH terms
Substances
LinkOut - more resources
Medical